UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035584
Receipt number R000040551
Scientific Title Continuous Administration of Tranexamic acid for acute intra Cerebral Hemorrhage: a hospital-based trial
Date of disclosure of the study information 2019/01/23
Last modified on 2023/07/24 15:58:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Continuous Administration of Tranexamic acid for acute intra Cerebral Hemorrhage: a hospital-based trial

Acronym

CATCH trial

Scientific Title

Continuous Administration of Tranexamic acid for acute intra Cerebral Hemorrhage: a hospital-based trial

Scientific Title:Acronym

CATCH trial

Region

Japan


Condition

Condition

Intra cerebral hemorrhage

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We search an effect of 14 days continuous administration of tranexamic acid for nonsurgical acute intra cerebral hemorrhage.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Glasgow Coma Scale at 1 week and at discharge

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

We assigned the patients to one group given 750 mg/day of tranexamic acid for 14 days.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

the patients who undergo nonsurgical treatment of spontaneous intracerebral hemorrhage

Key exclusion criteria

GCS <9; treatment window >8h; intracerebral hemorrhage secondary to anticoagulation, thrombolysis, trauma, or a known underlying structural abnormality; patients for whom tranexamic acid was thought to be contraindicaterd; prestroke mRS >4; patients who receive surgical treatment; multiple intracerebral hemorrhage

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hirotaka
Middle name
Last name Inoue

Organization

Graduate School of Medical Sciences, Kumamoto University

Division name

Departments of Neurosurgery

Zip code

8608556

Address

1-1-1, Honjo, Chuo-ku, Kumamoto City, Kumamoto, Japan

TEL

096-373-5219

Email

hiro2866@gmail.com


Public contact

Name of contact person

1st name Yuri
Middle name
Last name Iwasaki

Organization

Hitoyoshi Medical Center

Division name

Clinical research center

Zip code

8688555

Address

35 Roujin-cho Hitoyoshi, Kumamoto, Japan

TEL

0966-22-2191

Homepage URL


Email

iwasaki-yuri@hitoyoshi.jcho.go.jp


Sponsor or person

Institute

Departments of Neurosurgery, Hitoyoshi Medical Center

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hitoyoshi Medical Center

Address

35 Roujin-cho Hitoyoshi, Kumamoto, Japan

Tel

0966-22-2191

Email

iwasaki-yuri@hitoyoshi.jcho.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 23 Day


Related information

URL releasing protocol

https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi

Publication of results

Unpublished


Result

URL related to results and publications

now analyzing

Number of participants that the trial has enrolled

35

Results

Ninety patients comprised the non-administration group. Univariate analysis showed that the mRS score on day 90 was better in the administration group. The mRS scores on the day of death or discharge suggested a favorable effect of tranexamic acid treatment. Multivariable logistic regression analysis showed that tranexamic acid treatment resulted in good mRS scores at day 90.

Results date posted

2021 Year 07 Month 22 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

age, sex, ICH location, ICH size, intraventricular hemorrhage (IVH) measurement (Modified Graeb Score), pre-onset mRS score, GCS score at admission, and antithrombotic drug history

Participant flow

The prognosis was investigated until 90 days later.

Adverse events

none

Outcome measures

The primary outcome was mRS score on day 90. The secondary outcomes included hematoma expansion on day 2, GCS score on day 7, and mRS score on the day of death or hospital discharge (whichever came first).

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 08 Month 05 Day

Date of IRB

2018 Year 08 Month 08 Day

Anticipated trial start date

2018 Year 08 Month 08 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 01 Month 18 Day

Last modified on

2023 Year 07 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040551


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name